LEGAL STATEMENT

The Information contained within the Service is either licensed from

third party information providers or is the intellectual property of EMIS.
This information –including the document to be made available to you- is
therefore protected by copyright laws, database rights, trademarks
and/or patents owned by the relevant party.

Except as otherwise permitted in the agreement (if any) between

the Subscriber and EMIS, or as otherwise expressly approved in writing
by EMIS, any reproduction, publishing, redistribution, sell, broadcast or
circulation of the Information to any third party is strictly prohibited. No
rights are granted to the Subscriber except the limited use rights. The
Subscriber may not store in electronic form any shared library or archive
of Information which could be used as a research application nor
remove, conceal or alter any copyright notices contained in the Service
or in this document.
SECTOR CAPSULE: PAEDIATRIC CONSUMER
HEALTH IN THE PHILIPPINES
01 Feb 2019
HEADLINES
Paediatric consumer health increases by 4% in current value terms in 2018, to reach PHP11.0 billion
The growing sophistication of young parents, due to the powerful impact of social media, ensures the
growth of the category
Paediatric analgesics sees the best performance in 2018, with a 6% increase in current value terms
The leading player in paediatric consumer health in 2018 is United Laboratories, with a value share of 37%
Paediatric consumer health is set to see a negligible value CAGR at constant 2018 prices in the forecast
period, reaching PHP11.2 billion in 2023

COMPETITIVE LANDSCAPE
United Laboratories (Unilab) invests strongly in marketing strategies that effectively appeal to its
target consumer base. However, the company is also highly capable of adapting to changes in the
market, such as being omnipresent. The company has taken advantage of the growth of distribution
channels by making its products accessible across numerous retail channels, from grocery retailers to
internet retailing. When it comes to product availability, Unilab has brands in vitamins, dietary
supplements and OTC, making it easy to reach a significant value share in paediatric consumer health
in 2018. The company also knows its consumers, which is why it offers products at different price
points, marketing schemes that appeal to mass Filipinos, and retail channels that are convenient for its
consumer base.
One of the ways in which companies compete is by bringing prices down to attract consumers.
However, this is unlikely to happen in the forecast period, with inflation rates rising in the country. It
would be more strategic to look at unresolved areas, in which young parents might be very interested
due to increased awareness and self-education.

© Euromonitor International 2019 www.euromonitor.com

EMISPDF ateneo@edu from 202.125.103.33 on 2019-10-11 11:19:59 BST. DownloadPDF.
Downloaded by ateneo@edu from 202.125.103.33 at 2019-10-11 11:19:59 BST. EMIS. Unauthorized Distribution Prohibited.
NATIONAL BRAND OWNERS AND THEIR BRANDS
Company Name (NBO)
Abbott Laboratories (Phils) Inc
Alliance in Motion Global Inc
Amway Philippines LLC
GlaxoSmithKline Philippines Inc
Merck Inc
Pfizer Philippines Inc
Reckitt Benckiser (Philippines) Inc
Sanofi-Aventis Philippines Inc
Taisho Pharmaceutical (Philippines) Inc
The Generics Pharmacy
Tynor Drug House Inc
UHS Essential Health Philippines Inc
United Laboratories Inc
Source: Passport by Euromonitor International
© Euromonitor International 2019
EMISPDF ateneo@edu from 202.125.103.33 on 2019-10-11 11:19:59 BST. DownloadPDF.
Downloaded by ateneo@edu from 202.125.103.33 at 2019-10-11 11:19:59 BST. EMIS. Unauthorized Distribution Prohibited.
Brand (GBO)
Vidaylin (Abbott Laboratories Inc)
Nutra Gummie (Alliance in Motion Global Inc)
Nutrilite (Amway Corp)
Ambrolex (GlaxoSmithKline Plc), Calpol (GlaxoSmithKline Plc), Drapolene
(GlaxoSmithKline Plc), Scott's Vitamin C Pastilles (GlaxoSmithKline Plc)
Sangobion (Procter & Gamble Co, The)
Clusivol (Pfizer Inc), Dimetapp (Pfizer Inc), Incremin (Pfizer Inc), Loviscol
(Pfizer Inc)
Strepsils Children (Reckitt Benckiser Group Plc (RB))
Bisolvon (Sanofi)
Tempra (Taisho Pharmaceutical Holdings Co Ltd)
Diacare (The Generics Pharmacy)
Cherifer (Tynor Drug House Inc)
USANA (USANA Health Sciences Inc)
Biogesic (United Laboratories Inc), Ceelin (United Laboratories Inc),
Enervon-C for Children (United Laboratories Inc), Ferlin (United
Laboratories Inc), Growee (United Laboratories Inc), Kiddilets (United
Laboratories Inc), Naprex (United Laboratories Inc), Neozep (United
Laboratories Inc), Nutrilin (United Laboratories Inc), Nutroplex (United
Laboratories Inc), Rashfree (United Laboratories Inc), Solmux (United
Laboratories Inc), United American Tiki-tiki Plus Vitamins (United
Laboratories Inc)
www.euromonitor.com
FORECAST

DEFINITIONS AND METHODOLOGY

Paediatric Consumer Health
Products only specifically designed, marketed and labelled for children's symptoms. Include
paediatric analgesics, paediatric cough, cold and allergy remedies, paediatric digestive remedies,
paediatric medicated skin care, nappy (diaper) rash treatments, paediatric vitamins and dietary
supplements.

Methodology
This report is derived from Euromonitor International’s Passport information system. Industry
research is carried out by a global team of more than 600 in-country analysts and is based on a core
set of research techniques:
National-level desk research, company research and analysis, store checking, trade interviewing with
national players and market analysis
International-level desk research, multinational company research and analysis, trade interviewing with
international players and market analysis

© Euromonitor International 2019 www.euromonitor.com

EMISPDF ateneo@edu from 202.125.103.33 on 2019-10-11 11:19:59 BST. DownloadPDF.
Downloaded by ateneo@edu from 202.125.103.33 at 2019-10-11 11:19:59 BST. EMIS. Unauthorized Distribution Prohibited.